September is Sickle Cell Awareness month.While the month itself is almost over, patients living with the disease face a daily ...
Imagine a world where a cure for sickle cell disease – the blood disorder that afflicts roughly one in every 365 Black ...
The RUBY Trial is showing promise in treating patients fighting sickle cell disease, and Ohio is setting a national standard for addressing health inequities.
Groundbreaking pharmaceutical firm Yunigen welcomed a high-ranking Kenyan official to its R&D and manufacturing facility ...
Rochester, N.Y. The classmates of a young woman who passed away from sickle cell disease are giving back in her memory.
After Pfizer withdrew its sickle cell drug from the market, patients with the condition and their doctors were left scrambling to figure out what to do.
Students, teachers, and staff at Rochester Prep rolling up their sleeves today to remember one of their late classmates.
On Friday, Sept. 27, lawmakers reintroduced the Sickle Cell Disease Treatment Centers Act. If passed, this bicameral bill ...
Pfizer’s sudden market withdrawal of sickle cell therapy Oxbryta, which some analysts predicted would reach $750 million in ...
Agios Pharmaceuticals (AGIO) stock was downgraded at Leerink Partners on Pfizer's (PFE) recent decision to withdraw sickle ...
The U.S. FDA approved Bristol Myers' new schizophrenia drug, the first of its kind in decades. Bavarian Nordic signed an ...
A man and woman, both with sickle cell, share what their experience was like finding love, and what prospective partners need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback